U.S. veterans magazine : breakthrough therapy for PTSD
The U.S. Food and Drug Administration (FDA) have hailed methylenedioxymethamphetamine (MDMA) a breakthrough treatment for people with post-traumatic stress disorder (PTSD). MDMA, also known as ecstasy, is a synthetic drug that alters mood and perception … David Nutt, a neuropsychopharmacologist at Imperial College London, told Science, “This is not a big scientific step. It’s been obvious for 40 years that these drugs are medicines. But it’s a huge step in acceptance.”
MAPS, the nonprofit organization has reached an agreement with the FDA under the Special Protocol Assessment Process for the design of two Phase 3 trials for MDMA-assisted psychotherapy for patients with severe PTSD in the near future … The drug’s ability to help people with PTSD cope with the lingering effects of trauma is attributed in large part to its capacity to produce feelings of euphoria, empathy, and heightened emotional and physical sensations – in other words, perhaps, giving sorely stressed brains the kind of neurochemical getaway that begets a little peace of mind. Those effects also seem to motivate recreational users, but unlike the self-dosed Saturday night version, official MDMA-assisted psychotherapy involves three administrations of the drug combined with established psychotherapeutic techniques.